GlassScriptPhysician profile
John David Black
NPI 1619105004
$344,187.47
in general payments reported to CMS, 2019-2025
19 companies · $45K in 2025
The $45K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $75K · 2021: $51K · 2022: $67K · 2023: $29K · 2024: $27K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $67K · Royalty Or License: $23K · Travel and Lodging: $7,265 · Food and Beverage: $4,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,125.00 |
| Royalty Or License | $22,540.53 |
| Travel and Lodging | $7,264.51 |
| Food and Beverage | $4,950.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $336,091.13 | 2019-2025 | |
| Stryker Corporation | $2,793.64 | 2019-2025 | T2, Variax, Gamma |
| Summit Surgical Corp. | $1,542.86 | 2023 | |
| Depuy Synthes Sales INC. | $1,333.89 | 2019-2025 | Na, Tfn-Advance, Actis |
| Skeletal Dynamics INC | $777.98 | 2023-2025 | Ijs, Implate, Align |
| Arthrex, INC. | $756.87 | 2023 | |
| Globus Medical, INC. | $275.62 | 2023 | Distal Femur Plate System, Proximal Tibia Plate |
| Sanara Medtech INC. | $122.40 | 2024 | Celleraterx |
| Carbofix Orthopedics INC | $112.41 | 2019 | |
| Orthalign INC | $102.86 | 2023 | Orthalign Plus |
| Kinamed, INC. | $81.44 | 2023 | |
| Innovation Technologies INC | $33.98 | 2022 | |
| Mimedx Group, INC. | $27.69 | 2025 | |
| Nevro Corp. | $25.78 | 2024 | Senza |
| Solventum Corporation | $25.45 | 2024 | Prevena |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $24.06 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $21.66 | 2023 | Cardiomems |
| Polynovo North America LLC | $19.84 | 2025 | Novosorb Btm |
| Organogenesis INC. | $17.91 | 2025 | Puraply Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John David Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.